Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001816338-20-000002
Filing Date
2020-06-29
Accepted
2020-06-30 13:39:12
Documents
1
Group Members
GTP AW FUND I, LLCGTP AW FUND II, LLC

Document Format Files

Seq Description Document Type Size
1 SCH 13G anderson13g3.txt SC 13G 3472
  Complete submission text file 0001816338-20-000002.txt   4898
Mailing Address 245 FIRST STREET, 3RD FLOOR CAMBRIDGE MA 02142
Business Address 245 FIRST STREET, 3RD FLOOR CAMBRIDGE MA 02142 617-500-8099
Compass Therapeutics, Inc. (Subject) CIK: 0001738021 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-90878 | Film No.: 201001808
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 44 SOUTH MAIN STREET 3RD FLOOR HANOVER NH 03755
Business Address
ANDERSON ERRIK (Filed by) CIK: 0001816338 (see all company filings)

Type: SC 13G